Xiaohe J. Li - Publications

Mechanism study of S100A4 influencing pulmonary fibrosis through the lncRNA MEG3/miR-147 pathway

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: June 29, 2026

Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

Journal: Molecules (Basel, Switzerland)

Published: April 17, 2026

Copanlisib ameliorates pulmonary fibrosis by modulating cellular autophagy through PI3K/Akt/mTORC1 pathway.

Journal: Journal of thoracic disease

Published: January 13, 2026

Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells.

Journal: Frontiers in immunology

Published: December 18, 2025

Corrigendum to "Fibroblast growth factor receptor inhibitors ameliorate metabolic dysfunction-associated steatohepatitis by modulating the glycine-glutathione-gut microbiota axis" [Free Rad. Biol. Med. 240 (2025) 410-425].

Journal: Free radical biology & medicine

Published: November 16, 2025

Nerandomilast attenuates Pantoea agglomerans-induced hypersensitivity pneumonitis by regulating M1 macrophage polarization and fibroblast activation.

Journal: Respiratory research

Published: October 07, 2025

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 23, 2025

The Genetic and Embryo-Fetal Developmental Toxicity Profile of the Novel Transgelin Agonist Deg-AZM: Ames, Micronucleus, Chromosomal Aberration, and Rat EFD Studies.

Journal: Biomedicines

Published: September 23, 2025

Preparation of biochar from biomass and co-combustion behavior mixed with anthracite: Intrinsic characteristics, kinetics and mechanism.

Journal: Bioresource technology

Published: September 03, 2025

Crizotinib attenuates bleomycin-induced pulmonary fibrosis via regulating fibroblast activation.

Journal: Journal of thoracic disease

Published: August 22, 2025

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: July 28, 2025

Preclinical Safety Profile of Deg-AZM, a Clinical-Stage New Transgelin Agonist: hERG Inhibition Study In Vitro, Cardiovascular-Respiratory Pharmacology, and Single/Repeated-Dose Toxicity in Beagle Dogs.

Journal: Biomedicines

Published: July 17, 2025